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Frantic efforts have been made up to this date to derive consensus for estimating renal function in critically ill
patients, only to open the Pandora's box. This article tries to explore the various methods available to date, the
newer concepts, and the uncared issues that may still prove to be useful in estimating renal function in intensive
care unit patients. The concept of augmented renal clearance, which is frequently encountered in critically ill
patients, should always be taken into account, as correct therapeutic dosage of drugs sounds vital which in turn
depends on correctly calculated glomerular filtration rate. Serum creatinine and creatinine-based formulae have
their own demerits that are well known and established. While Cockcroft-Gault and 4-variable modification of diet
in renal diseases formulae are highly inadequate in the intensive care setup for estimating glomerular filtration rate,
employing isotopic methods is impractical and cumbersome. The 6-variable modification of diet in renal diseases
formula fairs better as it takes into account the serum albumin and blood urea nitrogen, too. Jelliffe's and modified
Jelliffe's equations take into account the rate of creatinine production and volume of distribution which in turn
fluctuates heavily in a critically ill patient. Twenty-four-hour and timed creatinine clearances offer values close to
reality although not accurate and cannot provide immediate results. Cystatin C is a novel agent that offers a sure
promise as it is least influenced by factors that affect serum creatinine to a major extent. Aminoglycoside clearance,
although still in the dark area, may prove a simple yet precise way of estimating glomerular filtration rate in those
patients in whom these drugs are therapeutically employed. Optic ratiometric method has emerged as the most
sophisticated one in glomerular filtration rate estimation in critically ill patients.
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Critically ill patients with acute kidney injury (AKI) do
differ from patients who are not ill in so many ways.
Many mathematical formulae do exist to estimate the
glomerular filtration rate (GFR) in this population of
patients. AKI is common among hospitalized patients,
especially in critically ill ones [1-6]. A decline in kidney
function contributes to the accumulation of many drugs
[7-9]. An accurate assessment of kidney function is re-
quired to optimize drug administration as both overdos-
ing and underdosing of drugs may prove detrimental in
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Problems in GFR estimation in an intensive care unit (ICU)
set up
Critically ill patients often have rapidly fluctuating renal
hemodynamics in the setting of AKI, and changes of
GFR are poorly reflected by daily changes in serum
creatinine concentrations in patients with AKI [10].
Creatinine as a single parameter always has demerits in
non-steady states observed in ICU patients as it is al-
ways constantly released into the circulation, affected
by many factors including muscle mass and drugs [11-14].
Moreover, creatinine poorly differentiates between pre-
renal and intrinsic renal failures and approximately 50%
of renal mass has to be lost for the serum creatinine to
rise [15].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(ARC) in critically ill patients is either missed or not
understood. This is seen in ill patients who are on vaso-
pressors and deliberate fluid support. This is important
in calculating the dosage of drugs especially those with
narrow therapeutic range.
ARC in critically ill: an enigmatic concept
ARC is defined as estimated GFR > 130 ml/min. In a
study by Andrew Udy et al. [16], 17 of 20 patients (85%)
with traumatic brain injury who required saline infusion
and vasopressor agents to maintain the cerebral perfu-
sion pressure had ARC. Using timed urinary creatinine
clearance method to measure GFR, ARC was demon-
strated in burns [17,18], sepsis [19] and surgery, and in
ICU patients. Brown et al. [20] recorded a creatinine
clearance of 190 ml/min/1.73 m2 in a cohort of critically
ill postoperative patients. Recently, Fuster-Lluch et al. [21]
reported an incidence of 17.9% in a cohort of postopera-
tive and polytrauma patients, who were younger, with
lower Acute Physiology And Chronic Health Evaluation
(APACHE) II scores, higher diastolic blood pressures, and
higher urine output on the first morning of admission to
the ICU. Cytokine release from acute injury [22], the in-
nate immune and inflammatory responses to trauma [23],
and aggressive fluid resuscitation may promote increased
organ blood flow and enhanced excretory function. The
importance of the concept is quite obvious. This throws
light on the doses of renally excreted drugs and may mean
that standard dosing regimens are inadequate in patients
with ARC. Baptista et al. [24] examined the perform-
ance of four creatinine-based estimation equations in 86
patients with ARC. This post hoc analysis showed that
all the better known GFR equations underestimated the
measured creatinine clearance value. The list below
illustrates the practical problems in estimating GFR in
an ICU setup:
1. Rapidly fluctuating renal hemodynamics
2. Both overdosing and underdosing are problems
when GFR could not be estimated close to accuracy
3. Constantly changing volume status of the patient
4. Concept of ARC is not frequently applied in
calculating GFR leading to inadequate dosing of
drugs
5. Commonly used creatinine-based equations are
flawed in the critical care setting. Ideal methods like
inulin clearance become impractical in an ICU setup
Equations for estimating creatinine clearance/GFR
CG formula
(140 −Age in years) × Body weight in kg/72 × Serum cre-
atinine in mg/dl. If the patient is a female, multiply re-
sult by 0.85 (Table one in [25]).The 4-variable MDRD
GFR ¼ 186 Serum creatinineð Þ−1:154  Ageð Þ−0:203
If a patient is female, multiply result by 0.742 and if
black, multiply result by 1.212 [25].
The 6-variable MDRD
GFR ¼ 170  Serum creatinineð Þ−0:999  Ageð Þ−0:176
 BUNð Þ−0:170  Albð Þ þ 0:318
If female, multiply result by 0.762 and if black, multi-
ply result by 1.18 [25], where BUN = blood urea nitrogen
measured in mg/dl, Alb = serum albumin concentration
measured in g/dl.
Only few studies have attempted to improve estima-
tion of GFR in critically ill patients and these studies in-
cluded subjects with stable kidney function in various
settings [17,26-28].
Relatively accurate estimation of GFR in a non-steady
state as in AKI requires timed urine collections, which
is not always practically possible in a critically ill pa-
tient. To overcome this, Jelliffe introduced an equation
in 2002 [29,30].
Jelliffe's equation
Estimated GFR = {(Volume of distribution × (Serum
creatinine on day 1 − Serum creatinine on day 2)} +
Creatinine production) 100/1,440/Average serum cre-
atinine [29,30].
Creatinine production (mg/day) is computed using the
following equation:
29:305− 0:203 Ageð Þ½  Weight in kg
 1:037− 0:0338 Average creatinineð Þ½ 
Correction for gender ð0:85 for males and
0:765 for femalesÞ [29].
Jelliffe's equation obviously takes into account the
fluctuations of serum creatinine over time, which fre-
quently occurs in AKI in ICU and which is not consid-
ered in the above-mentioned Cockcroft-Gault (CG) and
Modification of Diet in Renal Diseases (MDRD) formu-
lae. Ongoing creatinine production is also taken into
consideration, a major merit. However, this does not
consider the fluid balance variations that could also
affect the serum creatinine [31]. Creatinine is a water-
soluble substance, and rapid, especially overzealous
fluid administration can lower the creatinine and falsely
overestimate the GFR [32]. To overcome this, a modifi-
cation was made, which adjusted each measured cre-
atinine to cumulative fluid balance. This requires the
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was referred to as modified Jelliffe's equation [29].
Modified Jelliffe's equation
Adjusted creatinine ¼ Serum creatinine in mg=dl
 Correction factor
Correction factor ¼ ½Hospital admission weight kgð Þ
0:6þ
X
Daily fluid balanceð Þ=
Hospital admission weight
 0:6 Creatinine clearance
in ml=min [29].
The 24-h creatinine clearance is usually determined
from a 24-h urine collection [32].
An example
In a 60-kg woman, if the serum creatinine is 1.4 mg/dl,
urine creatinine is 110 mg/dl, and urine volume is 1.4 l/day,
then creatinine clearance = [110 × 1.4]/1.4 = 110 l/day. This
value has to be multiplied by 1,000 to convert into
milliliter and then divided by 1,440 (the number of
minutes in a day) to convert into units of milliliter per
minute. Thus, creatinine clearance = [110 × 1,000]/
1,440 = 76.4 ml/min.
In a study known as PICARD (Programme to Improve
Care in Acute Renal Dysfunction) by Josee Bouchard
et al. [33], the GFR was estimated by CG, MDRD, Jelliffe's,
and modified Jelliffe's equations and was compared
with measured urinary creatinine clearance. Twelve
non-dialyzed, non-oliguric patients with consecutive
increases in creatinine for at least 3 and up to 7 days
were identified and taken into study. The GFR esti-
mated by Jelliffe's and MDRD equations correlated best
with urinary creatinine clearance. The degree of over-
estimation of GFR by CG, MDRD, and Jelliffe was 80%,
33%, and 10%, respectively, and the degree of under-
estimation of GFR of modified Jelliffe's equation was
2%. The relative overestimation of GFR in AKI with
both CG and MDRD will be more prominent when
baseline GFR is higher. Small absolute changes in
serum creatinine will be reflected as large relative
changes in GFR with a lower serum creatinine. Patients
with fluid accumulation had GFR overestimated the
most by CG and MDRD equations. In practice, it is im-
perative to adjust GFR for creatinine production and
fluid balance at the beginning of an AKI episode, when
the initial serum creatinine is within the normal or in
the near-normal range.Jelliffe's and modified Jelliffe's equations can be easily
integrated in a computer program to facilitate dosage
regimens of drugs that have a narrow therapeutic index.
It is important to highlight the magnitude of variation
among these available methods because GFR estimation
in AKI could be used to adjust drug dosing and could
also influence the timing of initiation of renal replace-
ment therapy.
Cystatin C - a real boon in GFR estimation
Cystatin C is a non-glycosylated protein produced by all
nucleated cells at a constant rate [34]. Its constant rate
of production [35], low molecular weight of 13 kDa, and
positive charge at physiological pH makes it a suitable
marker for glomerular filtration. It is reabsorbed and al-
most completely catabolized in the proximal tubule
[34,35]. It is found in relatively high concentrations in
many body fluids, especially in the seminal fluid, cere-
brospinal fluid, and synovial fluid [36,37]. It has multi-
tude of advantages including its extreme sensitivity to
small changes in GFR and higher diagnostic accuracy
than MDRD or CG formulae. Moreover, its concentra-
tion is least affected by infections, malignancies, steroid
therapy, inflammatory disorders, and muscle mass [38-45].
In a study by Patricia Villa et al. [46], serum creatinine,
serum cystatin C, and 24-h creatinine clearance were
determined in 50 critically ill patients (age 21–86 years;
mean APACHE II score 20 ± 9). Data showed that serum
cystatin C correlated better with GFR than creatinine (1/
cystatin C versus creatinine clearance, r = 0.832, P < 0.001;
1/creatinine versus creatinine clearance, r = 0.426, P =
0.002). Cystatin C was diagnostically superior to creatinine
(area under the curve for cystatin C 0.927 and for creatin-
ine 0.694). Half of the patients had AKI. Only 5 (20%) of
these 25 patients had elevated serum creatinine, whereas
76% had elevated serum cystatin C levels (P = 0.032). This
suggests that serum cystatin C is a better marker of GFR
than serum creatinine in critically ill patients.
Two equations can be used to estimate GFR from
cystatin C concentration:
(A) Grubb's equation [47]: GFR = 83.93 × Cystatin
C−1.676
(B) Larsson's equation [48]: GFR = 77.239 × Cystatin
C−1.2623; cystatin C is measured in mg/l.
CG and 4-variable MDRD: woefully inadequate in the
critical care setting
The CG formula was derived from creatinine clearance
based on 24-h urine collections in 249 subjects in a med-
ical ward in a veterans administration facility, for which
96% of patients were men mostly with mild renal dysfunc-
tion. The MDRD equation has its origin from a cohort of
outpatients based on 125I iothalamate clearances with
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variable MDRD equation uses only age, sex, race, and
serum creatinine level to estimate the renal function.
None of these equations has been thoroughly validated
among ill hospitalized patients [49,50]. The 6-variable
MDRD equation also adds albumin and BUN concentra-
tions into the model. This may be a more appropriate
equation in a critical care setup. In a study by Poggio et al.
[10], iodine-125 iothalamate clearances performed in 107
sick in-patients with renal dysfunction were compared
with estimated GFR from the 6- and 4-variable MDRD
and CG equations. Patients were also subdivided into
those having BUN/creatinine ratio of >20 and <20. Com-
pared with iothalamate GFR, the CG and MDRD formulae
performed poorly with respect to their ability to predict
actual GFR, as shown by their poor agreement and high
degree of bias. The 6-variable MDRD equation showed a
better concordance correlation coefficient compared with
the 4-variable MDRD equation and CG formula (0.66
versus 0.57 and 0.46, respectively; P < 0.01). High BUN/
creatinine ratios are the usual findings in hospitalized
patients, and estimation of GFR in this population does
pose a great challenge for the clinicians. In such situations,
the 6-variable MDRD may serve as a good option than the
other mathematical formulae in arriving at a relativelyTable 1 Salient features of various methods that could be em
Sl no Methods Merits
1 CG formula Easily computable
2 4-variable MDRD More accurate than CG. May offer value
variable MDRD in healthier patients wit
BUN/Cr ratio
3 6-variable MDRD BUN and serum albumin are taken into
accurate when BUN/CR ratio is increase
concordance correlation coefficient wh
with CG and 4-variable MDRD
4 CKD-EPI formula Greater precision and reliability when c
MDRD. More accurate when GFR >60 m
5 24-h creatinine clearance More accurate when compared to CG a
formulae
6 Jelliffe's equation Ongoing creatinine production and fluc
creatinine concentration over time are
account
7 Modified Jelliffe's equation Fluid balance variations of creatinine ar
into account
8 Serum cystatin C Less affected by non-renal factors. Sens
changes in so-called creatinine blind G
min); preferred agent in liver disease pa
9 Aminoglycoside clearance May serve as an easy method for GFR e
patients already on aminoglycosides. M
than 24-h creatinine clearance
10 Fiberoptic ratiometric
fluorescent analyzer method
Most accurate way of all. Rapid, inexpe
reproducible, and safe methodaccurate GFR whereas the same may not offer any advan-
tage over 4-variable MDRD in healthier subjects with pre-
served BUN/serum creatinine ratio [51-60].
Chronic kidney disease-epidemiology (CKD-EPI) equation
in critically ill patients
CKD-EPI collaboration developed a new equation to
measure GFR based on serum creatinine, age, gender,
and race:
CKD‐EPI : Estimated GFR
¼ 141 min serum creatinine=k; 1ð Þa
 max serum creatinine=k; 1ð Þ−1:209
 0:993age  1:018 if femaleð Þ
 1:159 if blackð Þ
[61] where k is 0.7 for females and 0.9 for male patients,
a is −0.329 for female patients and −0.411 for male pa-
tients, min indicates the minimum of creatinine/k or 1,
and max indicates the maximum of creatinine/k or 1). In
comparison to the MDRD equation, CKD-EPI has greater
precision and reliability, especially for GFR >60 ml/min
per 1.73 m2. However, to date, this equation has not been
evaluated in hospitalized patients. As its outcome is based
on serum creatinine, overestimation of GFR does occurployed to measure GFR in ICU setup
Demerits
Highly inaccurate in the critical care setup.
Considerable degree of GFR overestimation
close to 6-
h preserved
Dependency on creatinine. May not be accurate when
BUN/Cr ratio is increased. Does not take into account
blood urea nitrogen and albumin. Overestimation of




Dependency on creatinine. Ongoing creatinine
production and its fluid balance variations are not
taken into account. Less accurate when compared with
cystatin C and novel methods
ompared with
l/min/1.73 m2
Not validated extensively in hospitalized and sick
individuals. Dependency on serum creatinine
nd MDRD Collection of urine is an issue. Cannot provide
immediate results. Becomes a problem when rapid
administration of drugs is essential
tuations in
taken into
Does not take into account the variations in creatinine
concentration with respect to fluid balance





Expensive and unreliable in the presence of thyroid
dysfunction, may be affected in patients taking high
dose steroids with renal dysfunction
stimation in
ay be better
Giving aminoglycoside for renal function estimation
alone may not be wise or practically possible
nsive, Still experimental. Requirement of technical expertise.
Scarce studies in humans
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with low muscle mass, although much less when com-
pared with CG formula.
Aminoglycoside clearance in urine as a measure of GFR in
critical care patients: where do we stand?
Aminoglycosides might be used to estimate renal func-
tion because they are freely filtered, neither secreted
nor reabsorbed in the kidney, and have little non-renal
clearance. To date, conflicting results have been pro-
duced by studies on ICU patients in estimating renal
function, both good and poor. This method can be used
to estimate renal functions in ICU patients who are
therapeutically prescribed aminoglycosides, usually ami-
kacin, gentamycin, and tobramycin according to the
dosing standards. In a study by TE Jones et al. in an
ICU [62], gentamycin and tobramycin clearance was
compared with standard MDRD and CG formulae along
with serum cystatin C. These aminoglycosides were ad-
ministered over 30 min using a computerized pump,
and the first blood sample taken 30 min later. The sec-
ond sample was taken at a time estimated to be twice
the half-life of the drugs. These blood samples were also
used in the calculations of creatinine clearance from the
timed urine collections. The 2-h urine collection was
commenced when the aminoglycoside infusion started,
and the 24-h collection commenced at the end of the 2-
h collection. Gentamycin clearance performed the best,
being within 10% of the value on 44% of occasions and
within 20% on 78% of occasions. Gentamycin clearance
has previously been shown to be a better estimate of
creatinine clearance than the 24-h urine estimate in a
study using inulin as the comparator [63-66]. Giving
aminoglycosides for the estimation of renal function
alone may not be a wise option but in patients who are
therapeutically prescribed aminoglycosides, their clear-
ance may serve as one of the better options in estimat-
ing renal function.
Optic ratiometric method for GFR estimation: do the
advantages outweigh the question of its feasibility in an
intensive care setup?
Novel methods for the rapid estimation of GFR include
employment of portable fiberoptic ratiometric fluorescent
analyzer, predominantly tested in large animal models,
mainly in pigs and dogs, the two species in which the
results are supposed to approximate in humans. In this
novel method tested in animal models, an optical fiber
of <1-mm size that delivers excitation light and absorbs
fluorescent emissions is inserted into a central vein
through a commercial intravenous catheter. A mixture
of fluorescent chimeras of a small freely filterable re-
porter and large non-filterable plasma volume marker is
infused as a bolus, excited by light-emitting diodes, andthe in vivo signals were detected and quantified by
photomultiplier tubes in the tested species within an
hour. While the fluorescent chimera is used as a plasma
volume marker, the small highly fluorescent and highly
filterable reporter molecule is used to quantify the rate
of its plasma clearance, which in turn is the measure of
GFR. This method allows for the rapid, inexpensive,
safe, reproducible, and patient-friendly method of esti-
mating GFR in conditions where only a short time
frame is available to make clinical decisions, as in AKI
in a critical care setting. Exing Wang et al. [67], in their
animal model study, found that the portable fiberoptic
ratiometric fluorescent analyzer provided a rapid point-
of-care determination of GFR which was standardized
against the 6-h iohexol clearance from the plasma. Table 1
summarizes the overall features and characteristics of the
parameters and equations that could be employed to esti-
mate GFR in an ICU setup.
Conclusions
The concept of estimating renal function in critically
ill patients had always remained elusive. The issue of
ARC should be considered to avoid improper dosing of
drugs. CG and 4-variable MDRD equations should
better be avoided in ICU setup. Cystatin C, modified
Jelliffe's, Jelliffe's, and 6-variable MDRD equations could
be employed in that order to estimate renal function and
to provide instant and accurate results. While aminoglyco-
side clearance could be used in patients in whom they are
therapeutically used, optic ratiometric method provides
the most accurate and instant estimation of renal function
in critically ill patients, although large-scale studies in
humans are required to validate it.
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